- Records
- 19
- Recruiting
- 11
- Recruiting sites
- 613
- Countries
- 18
ClinicalTrials.gov registry snapshot / 2026-07-24Peptide trials,
Peptide trials,
without the maze.
Search every official registry record matched to 13 tracked peptide and next-generation weight-loss programs. Find current status, phase, enrollment, countries, US states, recruiting cities, postal areas, completion timing, and the direct NCT source.
268unique NCT records
13named programs
53countries represented
1,840recruiting cities
11registry result modules
Recruiting footprint by program
Study status is not drug rank.
Bar length shows registry-listed sites individually marked Recruiting. Larger programs can create larger counts. This does not compare efficacy, safety, approval odds, sponsor quality, or enrollment availability.
- Records
- 52
- Recruiting
- 10
- Recruiting sites
- 170
- Countries
- 7
- Records
- 37
- Recruiting
- 10
- Recruiting sites
- 73
- Countries
- 3
- Records
- 24
- Recruiting
- 10
- Recruiting sites
- 935
- Countries
- 28
- Records
- 27
- Recruiting
- 6
- Recruiting sites
- 1,581
- Countries
- 36
- Records
- 30
- Recruiting
- 5
- Recruiting sites
- 155
- Countries
- 6
- Records
- 8
- Recruiting
- 4
- Recruiting sites
- 339
- Countries
- 23
- Records
- 31
- Recruiting
- 3
- Recruiting sites
- 774
- Countries
- 34
- Records
- 15
- Recruiting
- 3
- Recruiting sites
- 3
- Countries
- 1
- Records
- 34
- Recruiting
- 2
- Recruiting sites
- 450
- Countries
- 27
- Records
- 9
- Recruiting
- 2
- Recruiting sites
- 4
- Countries
- 3
- Records
- 9
- Recruiting
- 1
- Recruiting sites
- 8
- Countries
- 1
- Records
- 5
- Recruiting
- 0
- Recruiting sites
- 0
- Countries
- 0
Official registry finder
Filter the exact records.
Search names, former codes, NCT IDs, sponsors, interventions, conditions, cities, and postal codes. Filtered URLs are shareable but intentionally excluded from search indexing so this page remains the canonical source.
10matching registry records
Snapshot timestampJuly 24, 2026 at 9:00 AM UTC
| Program and record | Status | Phase and enrollment | Locations | Primary completion | Registry update | Source |
|---|---|---|---|---|---|---|
| A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightNCT06143956 / Eli Lilly and Company | RecruitingVerified 2026-07 | Phase 21,481 estimated | 47 recruiting54 listed / 2 countries | Sep 2027estimated | Jul 20, 2026ClinicalTrials.gov | Open NCT06143956 ↗ |
| Efficacy of Mazdutide for Treating PCOSNCT06519656 / Shanghai Zhongshan Hospital | RecruitingVerified 2024-10 | Phase 1 / Phase 250 estimated | 1 recruiting1 listed / 1 countries | Dec 31, 2025estimated | Oct 24, 2024ClinicalTrials.gov | Open NCT06519656 ↗ |
| A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With ObesityNCT06862908 / Innovent Biologics (Suzhou) Co. Ltd. | RecruitingVerified 2025-07 | Phase 2141 estimated | 1 recruiting1 listed / 1 countries | Sep 24, 2026estimated | Jul 11, 2025ClinicalTrials.gov | Open NCT06862908 ↗ |
| A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2NCT06931028 / Innovent Biologics (Suzhou) Co. Ltd. | RecruitingVerified 2025-06 | Phase 3260 estimated | 1 recruiting1 listed / 1 countries | May 7, 2027estimated | Jun 29, 2025ClinicalTrials.gov | Open NCT06931028 ↗ |
| A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)NCT06937749 / Innovent Biologics (Suzhou) Co. Ltd. | RecruitingVerified 2025-11 | Phase 2165 estimated | 1 recruiting1 listed / 1 countries | Apr 30, 2026estimated | Nov 20, 2025ClinicalTrials.gov | Open NCT06937749 ↗ |
| GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)NCT07083154 / The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | RecruitingVerified 2026-03 | Phase 3420 estimated | 6 recruiting8 listed / 1 countries | Aug 1, 2029estimated | Mar 5, 2026ClinicalTrials.gov | Open NCT07083154 ↗ |
| A Study of IBI362 in Chinese Adolescents With Obesity or OverweightNCT07255209 / Innovent Biologics (Suzhou) Co. Ltd. | RecruitingVerified 2026-01 | Phase 3180 estimated | 1 recruiting1 listed / 1 countries | Oct 31, 2027estimated | Jan 8, 2026ClinicalTrials.gov | Open NCT07255209 ↗ |
| Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/ObesityNCT07469800 / Innovent Biologics (Suzhou) Co. Ltd. | RecruitingVerified 2026-05 | Phase 3336 estimated | 1 recruiting1 listed / 1 countries | Aug 1, 2026estimated | May 27, 2026ClinicalTrials.gov | Open NCT07469800 ↗ |
| ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight ManagementNCT07517042 / Shanghai Zhongshan Hospital | RecruitingVerified 2025-12 | Not applicable420 estimated | 13 recruiting13 listed / 1 countries | Dec 2028estimated | Apr 8, 2026ClinicalTrials.gov | Open NCT07517042 ↗ |
| GLP-1 Therapy After Bariatric Surgery in Chinese Patients With ObesityNCT07633639 / China-Japan Friendship Hospital | RecruitingVerified 2026-05 | Not applicable200 estimated | 1 recruiting1 listed / 1 countries | May 1, 2028estimated | Jun 8, 2026ClinicalTrials.gov | Open NCT07633639 ↗ |
Recruiting location footprint
Country and US state routes.
Counts are site observations across registry records, not unique facilities. The same research center can appear in multiple studies. Open the exact NCT record before treating a location as current.
Clinical trial finder FAQ
Status, location, and enrollment are different fields.
These answers prevent the most common registry-search errors before a reader follows an official source.
Are any Retatrutide clinical trials recruiting?
Yes. This 2026-07-24 snapshot contains 2 Retatrutide registry records with an overall Recruiting status and 450 listed sites individually marked Recruiting. Overall status does not mean every site is open, and neither status establishes eligibility or enrollment. Open the exact NCT record and verify the individual location before contacting a study team.
How do I find a peptide clinical trial near me?
Enter a city or postal code, optionally add a country or US state, and then open the exact ClinicalTrials.gov record. This finder retains location rows individually marked Recruiting but omits facility and personal contact fields. Confirm current recruitment, eligibility, official contact route, and travel requirements on the registry. Peptide Local does not enroll participants.
Does Recruiting mean I can join the trial?
No. Recruiting is a registry status, not an eligibility decision or appointment. A study can be recruiting overall while some listed locations are not yet recruiting, active but closed, completed, suspended, or missing a current site status. The study team applies the protocol's eligibility and consent process.
Are the drugs in this clinical trial finder FDA approved?
A ClinicalTrials.gov record is not FDA approval. The finder covers investigational programs and can also include studies involving components or comparators with separate regulatory histories. Approval must be verified on the exact FDA label or regulator record, not inferred from a phase, sponsor, trial result, or recruiting status.
Why do only some registry records show posted results?
11 of 268 records in this snapshot expose a ClinicalTrials.gov results module. A record without posted registry results can still have a publication or sponsor announcement elsewhere, while a posted module still requires careful interpretation. Results availability is not a quality rank.
How current is the peptide clinical trial data?
The registry data timestamp is July 24, 2026 at 9:00 AM UTC. The refresh workflow searches exact intervention names and aliases, deduplicates by NCT ID, preserves multi-program studies, and stores overall and individual-site status separately. Registry fields can change after that timestamp, so the direct source remains authoritative for enrollment decisions.
Evidence boundary
A registry finder, not an enrollment service.
A dated transformation of ClinicalTrials.gov intervention-search records for thirteen named Peptide Local pipeline programs. Study sponsors or investigators submit and maintain registry records. Overall status, individual-site status, enrollment, locations, completion dates, and results availability can change. Recruiting status does not establish eligibility, enrollment, treatment access, regulatory approval, routine availability, or a favorable benefit-risk conclusion.
Peptide Local omits personal contact details and does not screen participants, recommend a protocol, interpret eligibility, arrange treatment, or authenticate commercial products that reuse an investigational program's name.
Read the official API documentation ↗Understand evidence categories →